The new AFM-Téléthon quarterly watch is out!
It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!
Home >
Non classé
Focused Ultrasound: the brain finally accessible to gene therapy for Leigh Syndrome
The main obstacle to treating Leigh syndrome is the blood–brain barrier, the brain’s ultra-selective protective… Read More »Focused Ultrasound: the brain finally accessible to gene therapy for Leigh Syndrome
Young PhD: submit your application for the 2026 Ouvrir les yeux Hope Prizes without delay!
The Ouvrir les yeux (OLY) association awards two prizes to young PhD graduates in science,… Read More »Young PhD: submit your application for the 2026 Ouvrir les yeux Hope Prizes without delay!
Publication of the Repères “Mitochondrial Diseases”
AFM-Téléthon has just published a Repères Savoir & Comprendre dedicated to mitochondrial diseases. The aim of this guide is… Read More »Publication of the Repères “Mitochondrial Diseases”
TK2 Deficiency: Kygevvi® on the verge of approval in Europe
Kygevvi®, the treatment developed by UCB for thymidine kinase 2 deficiency (TK2d), has just received… Read More »TK2 Deficiency: Kygevvi® on the verge of approval in Europe
The new AFM-Téléthon quarterly watch is out!
It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!
EuroMIT 2026 back in France, in Angers!
The EuroMIT 2026 International Congress on Mitochondrial Diseases will take place from 30 May to… Read More »EuroMIT 2026 back in France, in Angers!
TK2 deficiency: first treatment approved in the United States
Kygevvi®, the treatment developed by UCB for thymidine kinase 2 deficiency (TK2d), was approved by… Read More »TK2 deficiency: first treatment approved in the United States
The new AFM-Téléthon quarterly watch is out!
It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!